7th Annual Neuro-Oncology Review Course
November 16, 2022


              

This activity is jointly provided by Global Education Group and Society for Neuro-Oncology

Target Audience
Practicing physicians, residents and fellows, medical students, nurse practitioners, nurses, and all those interested in reviewing and enhancing their knowledge in the principles of clinical Neuro-Oncology.

Statement of Need/Program Overview
The Neuro-Oncology Review Course was developed in cooperation with the American Academy of Neurology (AAN) to provide junior neuro-oncologists, fellows, residents, nurse practitioners and physician assistants who attend the SNO Education Day and Scientific Meeting with a concise overview of Neuro-Oncology clinical knowledge, as well as preparation for Neuro-Oncology and oncology boards.  SNO membership includes nationally and internationally recognized leaders in the field and will provide faculty for the program. The United Council for Neurologic Subspecialties (UCNS), a nonprofit organization that accredits training programs (fellowships) in neurologic subspecialties and awards certification to physicians who demonstrate their competence in these subspecialties, has developed a Core Curriculum for Neuro-Oncology Certification. This Core Curriculum helped to guide development of the content of this review course. Content was designed to fulfill the curriculum elements while avoiding undue duplication with the SNO Education Day and Scientific Program.

Educational Objectives

• Describe multidisciplinary treatment modalities for the management of primary and secondary CNS tumors.
• Recognize the signs and symptoms of medical complications affecting Neuro-Oncology patients.
• Identify the most common pediatric CNS tumors and available treatment options.
• Identify strategies to integrate supportive and palliative care into the care of patients with primary and metastatic cancers of the CNS.
• Discuss primary CNS brain tumors seen in Neuro-Oncology practice.
• Discuss treatment and management of rare CNS tumors.
• Identify genetic predisposition syndromes in CNS tumors.

Faculty
Please click here to view the faculty. 

Program Agenda
Please click here to view the program.

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Society for Neuro-Oncology. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation
Global Education Group designates this live activity for a maximum of *10.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or
cme@globaleducationgroup.com

Instructions to Receive Credit
In order to receive credit for this activity, the participant must have attended the sessions in-person (you cannot claim CME for on-demand sessions), complete the overall program evaluation and session evaluations by logging in to this website or the conference mobile app by using the users registration login. 

For step-by-step instructions, click here. 

Deadline to claim CE Credit is Friday, March 3rd, 2023.


Refund/Cancellation Policy
The deadline for cancellations with refund is Thursday, November 3, 2022. Cancellations must be received in writing and a $50 cancellation fee will be assessed. Cancellations received after the deadline date cannot be refunded, but the meeting registration can be transferred to another person with written authorization.

Please note that your SNO membership must be current if you have chosen to register as a SNO member. SNO reserves the right to confirm that you have registered in the correct category.

Email all cancellation and transfer requests to Program Registrar Caroline Noor, caroline@soc-neuro-onc.org.

Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated

Disclosure list of all individuals in control of content for the program can be found by clicking here.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Society for Neuro-Oncology do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.